A New Human Blood–Retinal Barrier Model Based on Endothelial Cells, Pericytes, and Astrocytes
Claudia G. Fresta(University of Catania), Claudio Bucolo(University of Catania)
Cited by 78
Related Papers
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
|Frontiers in Pharmacology|2015|83
Gabapentin Attenuates Ocular Inflammation: In vitro and In vivo Studies
|Frontiers in Pharmacology|2017|54
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage
|Frontiers in Pharmacology|2021|45
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy
|Frontiers in Pharmacology|2022|35
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice
|Journal of Neuroinflammation|2021|27